Dalfampridine/Placebo [clinicaltrials_resource:b630173f3e64c178a851272c6f2b6dee]
intervention [clinicaltrials_vocabulary:intervention]
Dalfampridine/Placebo [clinicaltrials_resource:b630173f3e64c178a851272c6f2b6dee]
Bio2RDF identifier
b630173f3e64c178a851272c6f2b6dee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b630173f3e64c178a851272c6f2b6dee
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Weeks 1-3: Dalfampridine 10mg ...... et every 12 hours for 3 weeks.
intervention name [clinicaltrials_vocabulary:intervention-name]
Dalfampridine/Placebo
other name [clinicaltrials_vocabulary:other-name]
Ampyra (R)
identifier
clinicaltrials_resource:b630173f3e64c178a851272c6f2b6dee
title
Dalfampridine/Placebo
@en
type
label
Dalfampridine/Placebo [clinicaltrials_resource:b630173f3e64c178a851272c6f2b6dee]
@en